Aandelen in “Gezondheidstechnologie”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Gezondheidstechnologie”

23/06 · Nanalysis Provides Business Update Highlighting Quantum Technology Partnerships, $1Million in Non-Dilutive Non-Repayable Funding Award, Contract Wins and Corporate Activities · Persbericht

23/06 · Nanalysis Provides Business Update Highlighting Quantum Technology Partnerships, $1Million in Non-Dilutive Non-Repayable Funding Award, Contract Wins and Corporate Activities · Persbericht

23/06 · DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index · Persbericht

23/06 · Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) · Persbericht

23/06 · Nyxoah to Host Investor Day in New York on July 8, 2026 · Persbericht

23/06 · Acquisition of Own Shares · Persbericht

23/06 · Inkoop van eigen aandelen · Persbericht

23/06 · GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma · Persbericht

23/06 · EssilorLuxottica and Meta expand the accessibility of wearables category with new collection · Persbericht

23/06 · Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors · Persbericht

23/06 · Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients · Persbericht

23/06 · Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT · Persbericht

23/06 · QuidelOrtho Appoints Micah Young as Chief Financial Officer · Persbericht

23/06 · Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory · Persbericht

23/06 · Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal · Persbericht

23/06 · BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System · Persbericht

23/06 · ADMA Class Notice: ADMA Biologics Investors that Suffered Losses are Notified of the Imminent August 10 Securities Class Action Deadline · Persbericht

23/06 · INVESTOR DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit · Persbericht

23/06 · Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 22 06 2026] - (CGWL) · Persbericht

23/06 · Dimensional Fund Advisors Ltd. : Form 8.3 - ADVANCED MEDICAL SOLUTIONS - Ordinary Shares · Persbericht

23/06 · AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection · Persbericht

Mijn selecties